DDC and Parkinson disease: Both adeno-associated virus serotype 2 (AAV2)-mediated human AADC expression [5, 6] and lentivirus (LV)-mediated TH-AADC-GCH1 co-expression have been shown to be effective in alleviating symptoms of PD patients in clinical trials [7].